Table 1. Characteristics of study population.
| Characteristic | All patients (444) |
|---|---|
| Age (years) | 61.6 ± 13.1 |
| Males (%) | 206 (46.4) |
| Duration of dialysis (year) | 7.7 ± 5.0 |
| Diabetes mellitus (%) | 145 (32.7) |
| Previous CVD (%) | 93 (20.9) |
| Smoking (%) | 92 (20.7) |
| Systolic BP (mmHg) | 151 ± 77 |
| Diastolic BP (mmHg) | 78 ± 17 |
| Body mass index (kg/m2) | 22.9 ± 3.7 |
| Albumin level (g/dL) | 4.1 ± 0.3 |
| Triglyceride (mg/dL) | 152 ± 124 |
| Cholesterol level (mg/dL) | 175 ± 42 |
| Kt/V | 1.66 ± 0.23 |
| Cardiothoracic ratio | 0.5 ± 0.07 |
| Hemoglobin (g/dL) | 10.4 ± 1.3 |
| iPTH (pg/mL) | 193 ± 204 |
| Ferritin (μg/dL) | 636 ± 784 |
| Ca P product (mg/dL)2 | 48.2 ± 13.5 |
| Right side ABI | 1.03 ± 0.18 |
| Left side ABI | 1.03 ± 0.20 |
| Medications | |
| Anti-platelet use (%) | 154 (34.7) |
| RAS blockader use (%) | 90 (20.3) |
| Beta-blocker use (%) | 142 (32.0) |
| Statin use (%) | 143 (32.2) |
| All cause mortality events (%) | 127 (28.6) |
| Cardiovascular mortality events (%) | 93 (20.9) |
Abbreviations: CVD, cardiovascular disease; BP, blood pressure; iPTH, intact parathyroid hormone; Ca, calcium; P, phosphate; ABI, ankle-brachial index; RAS, renin-angiotensin system.